Holy Stone Healthcare Co., Ltd. (TPEX:4194)
6.40
-0.31 (-4.62%)
Oct 30, 2026, 1:30 PM CST
Holy Stone Healthcare Market Cap
Holy Stone Healthcare has a market cap or net worth of 934.23 million as of October 30, 2026. It is the 34,034th most valuable company in the world and the 2,055th biggest in Taiwan. Its market cap has decreased by 29.90% in one year.
Market Cap
934.23M
Enterprise Value
-194.23M
Revenue
n/a
Global Rank
Country Rank
#2,055 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 13, 2013, Holy Stone Healthcare's market cap has decreased from 5.54B to 934.23M, a decrease of -83.15%. That is a compound annual growth rate of -12.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 934.23M | -16.88% |
| Dec 31, 2025 | 1.12B | -40.54% |
| Dec 31, 2024 | 1.89B | -21.47% |
| Dec 29, 2023 | 2.41B | -36.56% |
| Dec 30, 2022 | 3.79B | 20.29% |
| Dec 30, 2021 | 3.15B | 17.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeoCore Technology | 1.22B |
| Enimmune | 1.15B |
| LabTurbo Biotech | 1.11B |
| Bio Preventive Medicine | 1.09B |
| Level Biotechnology | 999.55M |
| BiOptic | 992.66M |
| TCI GENE | 964.41M |
| GeneReach Biotechnology | 949.53M |